FDA Approves Magic Mushrooms for Clinical Trial on Depression

The U.S. Food and Drug Administration (FDA) has given approval to a clinical trial on psilocybin, the psychedelic ingredient found in magic mushrooms. COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received approval from the FDA for a clinical trial in psilocybin therapy for treatment-resistant … Continue reading

Source: FDA Approves Magic Mushrooms for Clinical Trial on Depression

Leave a Reply